The disclosure relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, to pharmaceutical compositions thereof, processes for making the same, and methods of use thereof.本發明涉及2-(環己基甲基)-N-{2-[(2S)-1-甲基吡咯烷-2-基]乙基}-1,2,3,4-四氫異喹啉-7-磺醯胺的富馬酸鹽及其藥物組合物、製造這些藥物組合物的製程及其使用方法。